Over 90% of samples show fiber disorganization, adipose replacement, and macrophage infiltration (Frich et al., 2021)
MT-2 has been studied in a range of peptide research environments involving melanocortin receptor signalling pathways, peptide-protein interaction mechanisms, and biochemical pathway investigations
reports receiving consulting fees from/and serving on advisory boards for Altimmune, Atria, Boehringer Ingelheim, Carmot Therapeutics, CinFina Pharma, Corteria, Currax Pharma, Eli Lilly, Enterin, Helicore Biopharma, Jamieson Wellness, Janssen Pharmaceuticals, Jazz Pharmaceuticals, Juvena Therapeutics, Kallyope, Morphic Medic/GI Dynamics, Novartis, Novo Nordisk, Pfizer, Prosciento, Senda Biosciences, Skye Bio/Cbeyond, Summit Clinical, Syntis Bio, Versanis, Veru Pharmaceuticals and Zealand Pharmaceuticals
However, high emotional eating, mood symptoms, or identity conflicts may moderate treatment response